Drugs, diplomacy and deliverance
A new cancer-killing medicine, developed in Jerusalem, has passed the scrutiny of the US Food and Drug Administration (FDA) and been approved for use. With the unwieldy name Doxorubicin-HCI Liposomal Injection, it is a modified chemotherapy medicine for the treatment of ovarian cancer, multiple myeloma and Kaposi’s Sarcoma. It is significantly less expensive, hence more […]